LIMBAL STEM CELL DEFICIENCY (LSCD)

Clinical trials for LIMBAL STEM CELL DEFICIENCY (LSCD) explained in plain language.

Never miss a new study

Get alerted when new LIMBAL STEM CELL DEFICIENCY (LSCD) trials appear

Sign up with your email to follow new studies for LIMBAL STEM CELL DEFICIENCY (LSCD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New eye drop trial offers hope for cornea damage patients

Disease control AVAILABLE

This trial provides access to experimental BRM421 eye drops for adults with mild to moderate limbal stem cell deficiency, a condition that can damage the cornea and affect vision. Participants will use the drops twice daily for at least 12 weeks and visit the clinic monthly for c…

Matched conditions: LIMBAL STEM CELL DEFICIENCY (LSCD)

Sponsor: BRIM Biotechnology Inc. • Aim: Disease control

Last updated Mar 09, 2026 14:24 UTC

LIMBAL STEM CELL DEFICIENCY (LSCD)

Get alerted when new LIMBAL STEM CELL DEFICIENCY (LSCD) trials appear

New eye drop trial offers hope for cornea damage patients